Products

Coinalytics

A return claim needs its inputs

coinalytics.co Finance / Financial Data & Research

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Fabio Federici
@fabfederici· 2,210 followers
Launched
12y ago
2014-02-03 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Show HN (3 pts)Launch

    Bitcoin Blockchain Address Tracker

    Oct 27, 2014 · 12y agoLaunch page

  • Launched on Product HuntLaunch

    Bloomberg for Bitcoin - Real-time analytics

    Jul 29, 2014 · 12y agoLaunch page

  • Launched on Product HuntLaunch

    Bitcoin analytics done right.

    Feb 5, 2014 · 12y agoLaunch page

  • Launched on BetaListLaunch

    Coinalytics – Real-time Bitcoin Analytics — Real-time Bitcoin Analytics

    Feb 3, 2014 · 12y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2019-02-28

KeywordMonthly volume
coinalyze7,210
coinanalyze220

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2014-02-05

Key pages

Weekly snapshots
coinalytics.co/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Coinalytics get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Coinalytics and what platforms does it support?
Coinalytics is catalogued under Financial Data & Research: A return claim needs its inputs. Supported platforms: Web.

Related products in this category

Finance / Financial Data & Research

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.